Figure 6
From: Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer

Whisker plot of change in markers pre- and on-treatment.
From: Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer
Whisker plot of change in markers pre- and on-treatment.